Taking drug Tamsulosin
PreclinicalSmall molecule
Taking drug Tamsulosin is one of 14 small molecule programs targeting Lower Urinary Tract Symptom. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
13
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
15 competitors in Lower Urinary Tract Symptom
#DrugCompanyPhaseTrials
1Flomax
SanofiApproved
Cialis
Eli LillyApproved
Vesicare
AstellasApproved
Rapaflo
AbbVieApproved
Myrbetriq
AstellasApproved
Lioresal
NovartisApproved
Uroxatral
AAdvanz Pharma
Approved
Detrol La
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Mitoq
AAntipodean Pharmaceuticals, Inc.
Phase 2
Hytrin
AAbbott
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Taking drug Tamsulosin. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details